Articulated stent

Abstract
An articulated stent for delivering through a bodily conduit, for example, a peripheral or coronary artery, which has one or more curved portions and for implantation therein. The articulated stent includes at least two substantially rigid segments and a flexible connector for connecting adjacent segments. The connector assumes a cylindrical configuration when relaxed and a differentially stretched and compressed curved configuration when flexed.
Description




FIELD AND BACKGROUND OF THE INVENTION




The present invention relates to stents which are implanted as part of a balloon angioplasty procedure within a bodily conduit of a living animal or a human to maintain patency. In particular, the present invention relates to articulated intravascular stunts for delivery through or implantation in a blood vessel having a curved portion.




Intravascular stents having a constricted diameter for delivery through a blood vessel and an expanded diameter for applying a radially outwardly extending force for supporting the blood vessel are known in the art. Articulated intravascular stents for either delivery through a curved blood vessel or implanted therein are also known in the art.




Self-expandable articulated stents are described, for example, in U.S. Pat. No. 5,104,404 entitled “Articulated Stent” to Wolff. Balloon expandable articulated stents are commercially available under the trade name Palmaz-Schatz Balloon-Expandable Stents from Johnson & Johnson Intervention Systems Co.




A prior art self-expandable articulated intravascular stent


10


deployed in a curved blood vessel


16


is now described with reference to

FIG. 1

which is, in actual fact,

FIG. 2

of the above referenced U.S. Pat. No. 5,104,404. Stent


10


is made up of a number of individual segments


12


articulated by hinges


14


connected at each end to segments


12


. Stent


10


is preferably fabricated from memory shape material, for example, nitinol, and as such is self expandable after delivery from a delivery system described in U.S Pat. No. 4,830,003 to Wolff et al. However, these prior art articulated intravascular stents suffer from a number of disadvantages both during delivery through a curved blood vessel and when implanted therein as will now described.




The delivery of stent


10


through: curved blood vessel


16


is more complicated than the delivery of a non-articulated stent in that stent


10


has to be angularly oriented such that its hinges


14


are located towards the convex portion of blood vessel


16


so that stent


10


can be flexed inward. In the present example, it will be noted that hinges


14


are located on the same side of segments


12


because blood vessel


16


has only a simple curve in one plane. It can be readily appreciated that delivery of stents through blood vessels which have one or more curved portions which are not in the same plane is even more complicated and generally requires specially constructed stents.




Even when implanted in a curved blood vessel


16


, stents


10


are shown to be lacking in that the gaps between segments


12


render the curved portion of blood vessel


16


without support. Furthermore, the gaps at the convex portion of blood vessel


16


are substantially greater than the gaps at the concave portion thereof, thereby inducing non-uniform and therefore undesirable stresses on blood vessel


16


.




Therefore, it would be highly desirable to have an articulated stent which does not require any particular angular orientation when being delivered through a curved bodily conduit and provides continuous and uniform support for both straight and curved portions of a bodily conduit when implanted.




It would also be highly desirable, the structure of a stent does not depend on the particular orientations of curved portions of a blood vessel.




SUMMARY OF THE INVENTION




The object of the present invention is for an articulated stent which can be delivered through a curved bodily conduit using a routine medical procedure and a conventional stent delivery system. Furthermore, the stent provides continuous and uniform support for both straight and curved portions of a bodily conduit when implanted. Still further, the structure of a stent and its support of a bodily conduit do not depend on the orientations of the curved portions of the conduit.




The objective of the present invention is achieved by an articulated stent, comprising: (a) at least two substantially rigid segments; and (b) a flexible connector for connecting adjacent segments, wherein the connector assumes a substantially cylindrical configuration when relaxed and a differentially stretched and compressed curved configuration when flexed.




After expansion the rigid segments of the stent preferably present a fine diamond shaped mesh having 1 mm long sides to provide continuous and uniform support for straight portions of a bodily conduit.




The connectors can be implemented as a plurality of substantially helical links connecting adjacent segments. Alternatively, the connectors can be implemented as links each having at least one kink. The connectors typically have between 8-24 links to provide continuous and uniform support for both straight and curved portions of a bodily conduit.




The stents have constricted diameters for intraluminal delivery and are then deformed, by the inflation of a balloon forming part of their catheter delivery system, to expanded diameters for applying radially outwardly extending forces for supporting the lumen of bodily conduits. The constricted and expanded diameters of the stents typically fall in the ranges of 10-3.5 mm and 3.5-10.0 mm, respectively.




The stents are preferably fabricated from low memory, more plastic than elastic, bio-compatible materials, for, example, stainless steel 316L, gold, tantalum, etc. which enables them to be plastically deformed from their constricted diameters to their expanded diameters.




A typical stent for implantation in a human coronary artery is 9-21 mm long comprising three to seven 2.2 mm long stent segments connected by two to six 1 mm long connectors such that the ends of the stent subtend between a 45° to 135° angle at a radius of curvature of approximately 9 mm when flexed.











BRIEF DESCRIPTION OF THE DRAWINGS




The invention is herein described, by way of example only, with reference to the accompanying drawings, wherein:





FIG. 1

shows a close-up view of a prior art articulated stent of deployed in a curved blood vessel;





FIGS. 2



a


and


2




b


show a preferred embodiment of an articulated stent, constructed and operative according to the teachings of the present invention, in its relaxed and flexed states before plastic deformation;





FIG. 2



c


shows the expanded stent of

FIG. 2

after plastic deformation;





FIG. 2



d


shows the stent of

FIG. 2

mounted on a catheter in its flexed state;





FIGS. 2



e


and


2




f


show the stent of

FIG. 2

before and after expansion by a balloon forming part of its catheter delivery system;




FIGS


3




a


and


3




b


show a second embodiment of an articulated stent, constructed and operative according to the teachings of the present invention, in its relaxed and flexed states before plastic deformation; and





FIG. 3



c


shows the expanded stent of

FIG. 3

after plastic deformation.











DESCRIPTION OF THE PREFERRED EMBODIMENTS




The present invention is of an articulated stent for delivering through a curved bodily conduit, for example, a peripheral or coronary artery of a living animal or a human and implantation therein as part of a balloon angioplasty procedure to maintain patency.




The principles and operation of the articulated stent of the present invention may be better understood with reference to the drawings and the accompanying description.




Referring now to the drawings,

FIGS. 2



a


-


2




c


show an articulated tent, Generally designated


100


, constructed and operative according to the teachings of the present invention, generally comprising a number of substantially rigid segments


102


connected by connectors


110


.




Segments


102


are preferably made up to present a fine diamond mesh of interconnected diamond shaped cells


108


having 1 mm sides on expansion as best seen in

FIG. 2



c


. Depending on the intended diameter of stent


100


, segments


102


typically comprise between 8-24 diamond shaped cells


108


.




Connectors


110


comprise links


112


connecting a front end


104


to tail end


106


of adjacent segments


102


. Links


112


preferably extend in a substantially helical fashion between apexes of diamond shaped cells


108


at front and rear ends


104


and


106


of adjacent segments


102


such that the number of links


112


equals the number of cells


108


. Links


112


are preferably evenly deployed around perimeters of segments


102


such that connectors


110


can be equally flexed in any direction and to provide continuous and uniform support to both straight and curved portions of a bodily conduit.




Alternate connectors


110


at front and rear ends


104


and


106


, respectively, of a segment


102


preferably have links


112


wound in clockwise and counter clockwise directions. Alternately winding connectors


110


ensures that the rotational displacement of links


112


and adjacent segments


102


relative to the walls of a blood vessel and more importantly the balloon of its delivery system is minimized when stent


100


is expanded.




It is particular feature of the present invention that connectors


110


have a generally cylindrical configuration when stent


100


is relaxed as best seen in

FIG. 2



a


and a differentially stretched and compressed curved configuration when stent


100


is flexed as best seen in

FIG. 2



b


. The flexed configuration is brought about by two relatively opposing displacements of links


112


. First, the differential stretching of connectors


110


occurs at the convex portion thereof denoted


114


by links


112


being displaced away from one another. Second, the differential compressing of




connectors


110


occurs at the concave portion thereof denoted


116


by links


112


being displaced towards one another.




Stent


100


has a constricted diameter for delivery through a curved bodily conduit as shown in

FIGS. 2



a


and


2




b


and an expanded diameter as shown in

FIG. 2



c


for supporting a bodily conduit. Stent


100


is preferably fabricated from low memory, more plastic than elastic, bio-compatible material, for example, stainless steel 316L, gold, tantalum, etc. which enables it to be plastically deformed from its constricted diameter to its expanded diameter. The constricted and expanded diameters of stent


100


typically fall in the ranges of 1:0-3.5 mm and 3.5-10.0 mm, respectively.




With reference now to

FIGS. 2



d


-


2




f


, stent


100


is shown overlying a balloon


118


forming part of its catheter delivery system


120


. Stent


100


is mounted on its catheter delivery system


120


in its constricted diameter state shown in

FIG. 2



e


for plastic deformation through inflation of balloon


118


to its expanded diameter shown in

FIG. 2



f


for supporting the walls of a bodily conduit. An exemplary stent for implantation in a human coronary artery, is typically 15 mm long, made up of five 2.2 mm long segments


102


connected by four 1 mm long connectors


110


and capable of flexion such that its ends subtend a 90° angle at a radius of curvature of approximately 9 mm.




The delivery of articulated stent


100


is considerably simpler than the delivery of prior art articulated stent


10


because stent


100


is equally flexible in all direction and therefore does not require a dedicated angular orientation to pass a particular curved portion. This advantage is particularly important for delivery through blood vessels having multiple curved portions. It is a further advantage of stent


100


over prior art stents


10


, that stent


100


provides continuous and uniform support along the entire length of a blood vessel by means of segments


102


and unflexed connectors


110


supporting straight portions thereof while connector portions


114


and


116


supporting convex and concave curved portions thereof, respectively.




With reference now to

FIGS. 3



a


and


3




b


, an articulated stent


122


is shown in which connectors


124


comprise links


126


having one or more kinks


128


. The design of connectors


124


is preferred to that of connector


110


because stent


100


may have a tendency to rupture balloon


118


due to two reasons. First, links


112


overlying the convex portion of balloon


118


have a tendency to be biased inward when stent


100


is flexed. Second, segments


102


display a rotational displacement relative to balloon


118


when stent


100


is expanded.




In this case, the differentially stretched and compressed curved configuration of connector


124


is brought about by two relatively opposing displacements of links


112


as before except that the differential stretching of connectors


124


at convex portion


114


occurs by kinks


128


being somewhat straightened out while the differential compressing of connectors


124


at concave portion


116


occurs by kinks


128


being more acutely bent.




In a similar fashion to stent


100


, stent


122


has a constricted diameter for delivery through a curved bodily conduit as shown in

FIGS. 3



a


and


3




b


and an expanded diameter as shown in

FIG. 3



c


for supporting a bodily conduit when implanted therein.




While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications and other applications of the invention may be made.



Claims
  • 1. An expandable stent comprising:(a) at least two substantially rigid segments, (i) each of said substantially rigid segments having a plurality of U or V-shaped regions in both the expanded and unexpanded configuration, the U or V-shaped regions being more open in the expanded configuration than in the unexpanded configuration, (ii) each of said substantially rigid segments presenting a substantially cylindrical structure defining a longitudinal passageway therethrough in both the expanded and unexpanded configurations, the cylindrical structure being shorter in length and wider in diameter in the expanded configuration than in the unexpanded configuration, (b) a flexible connector comprising a plurality of flexible links disposed between and connecting adjacent substantially rigid segments, (i) each of said flexible links connecting a U or V-shaped region of a substantially rigid segment with the nearest U or V-shaped region of the adjacent substantially rigid segment, (ii) each of said flexible links, when viewed laterally, having a first portion, a second portion and at least one area of inflection disposed between the first portion and the second portion, and (iii) none of said flexible links projecting into said longitudinal passageway in the unexpanded configuration.
  • 2. An expandable stent in accordance with claim 1, wherein each of said U or V-shaped regions, other than the U or V-shaped regions at the ends of the stent, is connected by a flexible link to a U or V-shaped region of the adjacent substantially rigid segment.
  • 3. An expandable stent in accordance with claim 1, wherein substantially all of said U or V-shaped regions, other than the U or V-shaped regions at the ends of the stent, are connected by a flexible link to a U or V-shaped region of the adjacent substantially rigid segment.
  • 4. An expandable stent in accordance with claim 1, wherein said substantially rigid segments are substantially rigid particularly when compared to said flexible connectors disposed between said substantially rigid segments.
  • 5. An expandable stent in accordance with claim 1 wherein the first portion and second portion are substantially straight.
  • 6. An expandable stent in accordance with claim 1 wherein said stent is expanded by an inflatable balloon inflated within said longitudinal aperture.
  • 7. An expandable stent comprising:(a) at least two substantially rigid segments, (i) each of said substantially rigid segments having a plurality of U or V-shaped regions in both the expanded and unexpanded configuration, the U or V-shaped regions being more open in the expanded configuration than in the unexpanded configuration, (ii) each of said substantially rigid segments presenting a substantially cylindrical structure defining a longitudinal passageway therethrough in both the expanded and unexpanded configurations, the cylindrical structure being shorter in length and wider in diameter in the expanded configuration than in the unexpanded configuration, (b) a flexible connector comprising a plurality of flexible links disposed between and connecting adjacent substantially rigid segments, (i) each of said flexible links having end points which are aligned substantially parallel to the longitudinal axis of the sent, (ii) each of said flexible links, when viewed laterally, having a first portion, a second portion and at least one area of inflection disposed between the first portion and the second portion, and (iii) none of said flexible links projecting into said longitudinal passageway in the unexpanded configuration.
  • 8. An expandable stent in accordance with claim 7, wherein each of said U or V-shaped regions, other than the U or V-shaped regions at the ends of the stent, is connected by a flexible link to a U or V-shaped region of the adjacent substantially rigid segment.
  • 9. An expandable stent in accordance with claim 7, wherein substantially all of said U or V-shaped regions, other than the U or V-shaped regions at the ends of the stent, are connected by a flexible link to a U or V-shaped region of the adjacent substantially rigid segment.
  • 10. An expandable stent in accordance with claim 7, wherein said substantially rigid segments are substantially rigid particularly when compared to said flexible connectors disposed between said substantially rigid segments.
  • 11. An expandable stent in accordance with claim 7, wherein the first portion and second portion are substantially straight.
  • 12. An expandable stent in accordance with claim 7, wherein said stent is expanded by an inflatable balloon inflated within said longitudinal aperture.
  • 13. An expandable stent comprising:(a) at least two substantially rigid segments, (i) each of said substantially rigid segments having a plurality of U or V-shaped regions in both the expanded and unexpanded configuration, the U or V-shaped regions being more open in the expanded configuration than in the unexpanded configuration, (ii) each of said substantially rigid segments presenting a substantially cylindrical structure defining a longitudinal passageway therethrough in both the expanded and unexpanded configurations, the cylindrical structure being wider in diameter in the expanded configuration than in the unexpanded configuration, (b) a flexible connector comprising a plurality of flexible links disposed between and connecting adjacent substantially rigid segments, (i) each of said flexible links connecting a U or V-shaped region of a substantially rigid segment with the nearest U or V-shaped region of the adjacent substantially rigid segment, (ii) each of said flexible links, when viewed laterally, having a first portion, a second portion and at least one area of inflection disposed between the first portion and the second portion, and (iii) none of said flexible links projecting into said longitudinal passageway in the unexpanded configuration.
  • 14. An expandable stent in accordance with claim 13, wherein said substantially rigid segments are substantially rigid particularly when compared to said flexible connectors disposed between said substantially rigid segments.
  • 15. An expandable stent in accordance with claim 13, wherein the first portion and second portion are substantially straight.
  • 16. An expandable stent in accordance with claim 13, wherein said stent is expanded by an inflatable balloon inflated within said longitudinal aperture.
RELATED PATENT APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 09/483,082 filed on Jan. 14, 2000 now U.S. Pat. No. 6,508,834 which is a continuation of U.S. patent application Ser. No. 09/026,750 filed Feb. 20, 1998 (now U.S. Pat. No. 6,059,811), which is a continuation of U.S. patent application Ser. No. 08/760,359 filed Dec. 4, 1996 (now U.S. Pat. No. 5,980,552), which is a continuation of U.S. patent application Ser. No. 08/455,462 filed May 31, 1995 (abandoned), which is a continuation of U.S. patent application Ser. No. 08/213,272 filed Mar. 17, 1994 (now U.S. Pat. No. 5,449,373).

US Referenced Citations (41)
Number Name Date Kind
4733665 Palmaz Mar 1988 A
4762128 Rosenbluth Aug 1988 A
4800882 Gianturco Jan 1989 A
4830003 Wolff et al. May 1989 A
4856516 Hillstead Aug 1989 A
4886062 Wiktor Dec 1989 A
4922905 Strecker May 1990 A
4950227 Savin et al. Aug 1990 A
4969458 Wiktor Nov 1990 A
4994071 MacGregor Feb 1991 A
5019085 Hillstead May 1991 A
5019090 Pinchuk May 1991 A
5035706 Giantureo Jul 1991 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5116365 Hillstead May 1992 A
5133732 Wiktor Jul 1992 A
5158548 MacGregor Oct 1992 A
5161547 Tower Nov 1992 A
5195984 Schatz Mar 1993 A
5282824 Gianturco Feb 1994 A
5314472 Fontaine May 1994 A
5330500 Song Jul 1994 A
5354308 Simon et al. Oct 1994 A
5354309 Schnepp et al. Oct 1994 A
5383892 Cardon et al. Jan 1995 A
5405377 Cragg Apr 1995 A
5441515 Khosravi et al. Aug 1995 A
5443496 Schwartz et al. Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5507767 Maeda et al. Apr 1996 A
5540712 Kleshinski et al. Jul 1996 A
5554181 Das Sep 1996 A
5643312 Fischell et al. Jul 1997 A
5649952 Lam Jul 1997 A
5651174 Schwartz et al. Jul 1997 A
5653727 Wiktor Aug 1997 A
5980552 Pinchasik et al. Nov 1999 A
6059811 Pinchasik et al. May 2000 A
6348065 Brown et al. Feb 2002 B1
6508834 Pinchasik et al. Jan 2003 B1
Foreign Referenced Citations (7)
Number Date Country
0 335 341 Apr 1989 EP
0 540 290 May 1993 EP
0 541 443 May 1993 EP
0 566 807 Oct 1993 EP
0 606 165 Jul 1994 EP
WO 9531945 Nov 1995 WO
WO 9603092 Feb 1996 WO
Non-Patent Literature Citations (1)
Entry
U.S. patent application Ser. No. 08/246,320, Burmeister et al., filed May 1994.
Continuations (5)
Number Date Country
Parent 09/483082 Jan 2000 US
Child 10/292759 US
Parent 09/026750 Feb 1998 US
Child 09/483082 US
Parent 08/760359 Dec 1996 US
Child 09/026750 US
Parent 08/455462 May 1995 US
Child 08/760359 US
Parent 08/213272 Mar 1994 US
Child 08/455462 US